Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Riluzole in children and adolescents with autism spectrum disorders
NCT01661855Phase 2Completed
- Sponsor
- Holland Bloorview Kids Rehabilitation Hospital
- Start
- Sep 2013
- Primary completion
- Sep 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of riluzole in Autism Spectrum Disorder (ASD), sponsored by Holland Bloorview Kids Rehabilitation Hospital. Primary endpoints: Social function at 12 weeks and Repetitive behaviors at 12 weeks. Started Sep 2013; status: completed.
02
Drugs
riluzole
03
Conditions
Autism Spectrum Disorder (ASD)
Beyond the preview
Go deeper on NCT01661855.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01661855.